Intracellular peptide assemblies for cancer therapy
Bing Xu, after receiving his BS and MS degrees from Nanjing University in 1987 and 1990, respectively, obtained his PhD in 1996 from the University of Pennsylvania. Before starting his independent research at the Hong Kong University of Science and Technology (HKUST)on the Aug. 2000, he was an NIH postdoctoral fellow at Harvard University. Dr. Xu was a tenured professor at HKUST until Jul. 2008 before he returned to Boston. He currently is a professor in the Department of Chemistry, Brandeis University. He has made pioneering contributions to metallogels, multifunctional magnetic nanoparticles, self-delivery drugs, supramolecular hydrogels, and enzyme-instructed self-assembly for in-situ anticancer nanomedicine. His current research focuses on the applications of enzymatic noncovalent synthesis in materials, biology, and medicine.
Palestra no Centro de Química “Intracellular peptide assemblies for cancer therapy”.
